Persistent elevated serum levels of intact parathyroid hormone after reoperatin for primary hyperparathyroidism and after pamidronate therapy

Turkish Journal of Pediatrics

Volumn 45, Issue 3, 2003, Pages 269-272

  Darcan, Sukran ^a   Çoker, Mahmut ^a   Aydinok, Yeşim ^a   Gökşen, Damla ^a   Özok, Geylani ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hypercalcemia; Hyperparathyroidism; Pamidronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM SENSING RECEPTOR; PAMIDRONIC ACID; PARATHYROID HORMONE;

ABDOMINAL DISTENSION; ANGIOGRAPHY; ARTICLE; BIOCHEMISTRY; BODY HEIGHT; BODY WEIGHT; BRACHIOCEPHALIC VEIN; CASE REPORT; CONSTIPATION; FAILURE TO THRIVE; FEMALE; FEVER; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; HYPERCALCEMIA; INFANT; MENTAL DEFICIENCY; MORTALITY; MOTOR RETARDATION; MUSCLE HYPOTONIA; NEUROLOGIC EXAMINATION; PARATHYROIDECTOMY; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIMARY HYPERPARATHYROIDISM; REOPERATION; SUBCUTANEOUS FAT; TENDON REFLEX; TREATMENT FAILURE; VOMITING;

ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; DIPHOSPHONATES; FEMALE; HUMANS; HYPERPARATHYROIDISM; INFANT; PARATHYROID HORMONE; PARATHYROIDECTOMY; REOPERATION;

EID: 0242410126     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pearce SH, Trump D, Wooding C, et al. Calcium sensing receptor mutations in familial benign hypercalcemia and hyperparathyroidism. J Clin Invest 1995; 2683-2692.
2. Aida K, Koishi S, Inoue M, et al. Familial hypocalciuric hypercalcemia associated with mutation in human Ca sensing receptor gene. J Clin Endocrinol Metab 1995; 80: 2594-2598.
3. Kobayashi Mm, Tanaka H, Tsuzuki K, et al. Two novel missense mutations in calcium sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2716-2719.
4. Le HN, Norton JA. Surgical management of hyperparathyroidism. In: Degroot JL, Jameson LJ (eds). Endocrinology (4th ed) Vol. 2. Philadelphia: WB Saunders; 2001: 1111-1119.
5. Orwoll E, Silbert J, McClung M. Asymptomatic neonatal familial hypercalcemia. Pediatrics 1982; 69: 109-111.
6. Marx SJ, Attie MF, Spiegel AM, et al. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 1982; 306: 257-264.
7. Silverberg JS, Bilezikian JP. Primary Hyperparathyroidism. In: Degroot JL, Jameson LJ (eds). Endocrinology (4th ed) Vol. 2. Philadelphia: WB Saunders; 2001: 1075-1090.
8. Pattou FN, Pellissier LC, Noel C, Wambergue F, Huglo DG, Proye CA. Supemumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 2000; 24: 1330-1334.
9. Henry JF, Defechereux T, Raffaelli M, Lubrano D, Iacobone M. Supernumerary ectopic hyperfunctioning parathyroid gland: a potent pitfall in surgery for sporadic primary hyperparathyroidism. Ann Chir 2000; 125: 247-252.
10. Kutluk MT, Hazar V, Akyüz C, Varan A, Büyükpamukçu M. Childhood cancer and hypercalcemia: report of a case treated with pamidronate. J Pediatr 1997; 130: 828-831.
11. Laiteinen K. Investigator's Brochure. Helsinki: 1995; 6-23.
12. Fitton A, Mc Tavish D. Pamidronate: a review of its pharmacological properties and theurapeutic efficacy in resorptive bone disease. Durgs 1991; 41: 289-318.
13. Pfeilschifter J, Ziegler R. Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome. Med Klin 1998; 93: 352-359.
14. Chapuriat RD, Delmans PD, Liens D, Meunnier PJ. Long term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12: 1746-1752.
15. Plotkin H, Rauch F, Bishop NJ, et al. Pamidronate treatment of severe osteogenesis imperfecta in children under three years of age. J Clin Endocrinol Metab 2000; 85: 1846-1850.
16. Bembi B, Parma A, Bottega M, et al. Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 1997; 131: 622-625.
17. Sellers E, Sharma A, Codd C. The use of pamidronate in three children with renal disease. Pediatr Nephrol 1998; 12: 778-781.
18. Attard TM, Dhawan A, Kaufmann SS, Collier DS, Lagnas AN. Use of disodium pamidronate in chidren with hypercalcemia awaiting liver transplantation. Pediatr Transplant 1998; 2: 157-159.